New brain tumor drug tested in japanese children
NCT ID NCT07441707
Summary
This early-stage study aims to check the safety and measure how the body processes the drug tovorafenib in Japanese children and young adults with recurrent low-grade brain tumors that have a specific genetic change (BRAF-altered). All participants will take the drug orally once a week for up to two years. The study will also see if the drug helps shrink the tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW-GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.